Kay Brinkmann
7Patents
3h-index
6Co-inventors
46Inventor score
Filing activity: Jan 26, 2000 → Nov 22, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6403345B1 | Obtainment of &ggr;-linolenic acid from protozoa of the genus colpidium | Emerging Cross-Sectional Technologies | 23 | Expired |
| US8613936B2 | Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements | Chemistry; Metallurgy | 5 | Active |
| US8394385B2 | Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines | Chemistry; Metallurgy | 5 | Active |
| US9163237B2 | Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements | Chemistry; Metallurgy | 1 | Active |
| US9828414B2 | Pr13.5 promoter for robust T-cell and antibody responses | Chemistry; Metallurgy | 1 | Active |
| US10111946B2 | Poxviral vectors for low antibody response after a first priming immunization | Chemistry; Metallurgy | 0 | Active |
| US11028130B2 | PR13.5 promoter for robust T-cell and antibody responses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.